MedTrace Logo

Brief Title: a Clinical Study to Assess Gingivitis

NCT06659471 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-10-26

No results posted yet for this study

Summary

The objective of this learning clinical study is to evaluate the effects of formulation chemistry on gingivitis.

Conditions

  • Gingival Diseases

Interventions

DRUG

0.76% Sodium Monofluorophosphate Dentifrice

Whole mouth brushing with a toothpaste, twice daily for the duration of the study.

DRUG

0.454% Stannous Fluoride Dentifrice

Whole mouth brushing with a toothpaste, twice daily for the duration of the study.

Sponsors & Collaborators

  • Procter and Gamble

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-07
Primary Completion
2022-06-06
Completion
2022-06-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06659471 on ClinicalTrials.gov